Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance.
- NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_assertion wasGeneratedBy ECO_0000203 NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance.
- NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_assertion wasDerivedFrom befree-20150227 NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance.
- NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_assertion SIO_000772 21406037 NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance.
- NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_assertion evidence source_evidence_literature NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance.
- NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_assertion description "[The amplification of certain RTKs (ErbB2, c-Met and FGFR2) is associated with gastric cancer progression, but the only recently approved inhibitor is trastuzumab, ErbB2-targeting antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401792.RAS0dGSejgBvoiag-EeKFg5zBz-mmwdE8_rlKcc6xVGaA130_provenance.